Home / Management Team

The Management Team

​The many decades of experience these key team members have in the cardiovascular field means they thoroughly understand this industry segment, the nuances of regulatory approval, and are well suited to face the challenges that lie ahead.

Their expertise will allow them to be efficient both in time and financial management bringing their vision to fruition, and having a wide-ranging impact on the patients’ quality of life.

Anthony Comerota,
MD, FACS, FACC
  • Vascular Surgeon
  • Medical Director of the Heart & Vascular Institute Inova General Hospital

Akhilesh K. Sista,
MD, FSIR, FAHA
  • Section Chief of Vascular and Interventional Radiology NYU-Langone School of Medicine
Kenneth Rosenfield,
MD, FACC, MSCAI
  • Section Head for Vascular Medicine and Intervention Chairman, STEMI & Acute MI QI Committee Massachusetts General Hospital

  • Co-founder of the PERT Consortium
Victor F. Tapson,
MD, FRCP, FCCP
 
  • Director VTE & Pulmonary Vascular Disease Research Program Associate Director of the Pulmonary and Critical Care Division Cedars-Sinai Medical Center
  • Past President of the PERT Consortium

Scientific Advisory Board
Our Commitment to You

“ The BEC will have such a tremendous impact on the populations that suffer from these diseases. Our team is working every day to bring forward this transformational technology which will really have a positive impact on treating patients around the world.”

                               

       -  Marvin Woodall

          Thrombolex Chairman & CEO

Available Now:
BASHIR_2018_Logo_Full_Color-stacked.jpg

The BASHIR™

Endovascular Catheter is intended for the controlled and selective infusion of physician­ specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.

The BASHIR™ Plus

Endovascular Catheter 

is intended for the controlled and selective infusion of physician­ specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.

The BASHIR™ +30

Endovascular Catheter 

is intended for the controlled and selective infusion of physician­ specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.

The BASHIR™ N-X

Endovascular Catheter is a device intended for the localized infusion of physician-specified fluids, into the peripheral vasculature, including the pulmonary arteries.

BASHIR_PLUS10_Full_Color.jpg

The BASHIR™ +10

Endovascular Catheter 

is intended for the controlled and selective infusion of physician­ specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.

The BASHIR™ +40

Endovascular Catheter 

is intended for the controlled and selective infusion of physician­ specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.

The BASHIR™ S-B

Endovascular Catheter is a device intended for the localized infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature.

The BASHIR™ +20

Endovascular Catheter 

is intended for the controlled and selective infusion of physician­ specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.

Need more details? Contact us.

We are here to assist. Contact us by phone, email or via our social media channels.

CONTACT US